We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RPC:NYSERidgepost Capital, Inc. Analysis

Data as of 2026-05-31 - not real-time

$8.28

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Ridgepost Capital posted earnings that modestly beat expectations, reinforcing the resilience of its fee‑based model. The company’s revenue is expanding at a healthy pace and margins remain solid, indicating strong operational execution. However, the market price sits far above the discounted cash flow estimate, suggesting a sizable valuation gap. The stock trades below its longer‑term moving average while technical momentum indicators have turned bearish, pointing to short‑term downside pressure. Leverage is elevated, with debt roughly matching equity, which tempers the attractiveness of the dividend given a high payout ratio. Overall, the blend of robust growth fundamentals and a stretched valuation creates a nuanced outlook.
The immediate risk environment is heightened by notable price volatility and a beta that exceeds the market, while the asset‑management sector faces moderate regulatory scrutiny. International exposure adds a layer of geographic diversification but also introduces additional operational complexity. The dividend appears vulnerable under current cash‑flow and debt dynamics, raising questions about its long‑term sustainability. Investors should weigh the strong earnings momentum against the overvalued price and elevated risk profile when formulating a position.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish technical momentum
  • price significantly above intrinsic estimate
  • elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • steady revenue growth and solid margins
  • ongoing dividend yield offset by leverage concerns
  • moderate sector and regulatory risk

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • potential for earnings expansion as AUM grows
  • improved valuation if market re‑rates the stock
  • diversified international footprint supporting future growth

Key Metrics & Analysis

Financial Health

Revenue Growth10.90%
Profit Margin7.70%
P/E Ratio39.4
ROE7.19%
ROA6.35%
Debt/Equity100.19
P/B Ratio2.6
Op. Cash Flow$44.8M
Free Cash Flow$36.2M
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI52.4
Support$7.83
Resistance$8.88
MA 20$8.34
MA 50$7.80
MA 200$9.69
MACDBearish
VolumeDecreasing
Fear & Greed Index94.07

Valuation

Fair Value$3.51
Target Price$13.50
Upside/Downside63.04%
GradeOvervalued
TypeBlend
Dividend Yield1.93%

Risk Assessment

Beta1.64
Volatility32.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.